Interferon-gamma - Hayashibara
Alternative Names: Interferon-gamma-n1; Ogamma; Ogamma 100; OH 6000Latest Information Update: 23 Dec 2021
Price :
$50 *
At a glance
- Originator Hayashibara
- Developer Hayashibara; Otsuka Pharmaceutical
- Class Antineoplastics; Antivirals; Interferons; Lymphokines
- Mechanism of Action Interferon gamma stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Skin cancer
Most Recent Events
- 26 Jun 2000 Hayashibara and Amarillo collaborate on inhalation formulation
- 05 Aug 1997 Launched for Skin cancer in Japan (Parenteral)
- 03 Oct 1996 Preregistration for Skin cancer in Japan (Parenteral)